Dewang Zhou

Shenzhen Third People’s Hospital, Shenzhen University

Papers

Total Citations

138

H-Index

About

Dewang Zhou is pioneering the frontier of autonomous nanorobotics for precision medicine, with a focus on subcellular organelle targeting and biocompatible design. His major contributions include the development of the first autonomous metal-organic framework nanorobots capable of active, controlled propulsion to reach mitochondria for cancer therapy—a breakthrough that addresses the long-standing challenge of intracellular nanorobotic manipulation. This work, published in 2023, has already garnered 95 citations, underscoring its rapid impact. In 2024, Zhou advanced the field further by introducing bacterial outer membrane vesicle nanorobots, an enzyme-powered system that leverages natural biological materials to overcome the biocompatibility and functional limitations of inorganic nanorobots. This innovation, with 43 citations, represents a paradigm shift toward fully biological nanorobotic platforms. Zhou’s research uniquely bridges materials science, synthetic biology, and nanomedicine, offering transformative tools for targeted therapy. His work is notable for its translational potential, particularly in mitochondria-targeted treatment, and positions him as a rising leader in the next generation of therapeutic nanorobotics.